Orion Portfolio Solutions LLC cut its position in shares of Perrigo Company plc (NYSE:PRGO – Free Report) by 2.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 83,488 shares of the company’s stock after selling 1,905 shares during the period. Orion Portfolio Solutions LLC’s holdings in Perrigo were worth $2,190,000 as of its most recent SEC filing.
Other large investors have also made changes to their positions in the company. Venturi Wealth Management LLC bought a new position in Perrigo during the third quarter valued at approximately $56,000. KBC Group NV raised its holdings in shares of Perrigo by 25.1% during the 3rd quarter. KBC Group NV now owns 4,517 shares of the company’s stock valued at $118,000 after purchasing an additional 905 shares in the last quarter. Voisard Asset Management Group Inc. boosted its holdings in Perrigo by 9.7% in the third quarter. Voisard Asset Management Group Inc. now owns 5,100 shares of the company’s stock worth $134,000 after purchasing an additional 450 shares in the last quarter. Atria Investments Inc bought a new stake in Perrigo in the third quarter worth $208,000. Finally, CWM LLC increased its position in Perrigo by 877.0% during the second quarter. CWM LLC now owns 8,197 shares of the company’s stock worth $210,000 after buying an additional 7,358 shares during the last quarter. Institutional investors own 95.91% of the company’s stock.
Perrigo Price Performance
NYSE PRGO opened at $27.30 on Thursday. Perrigo Company plc has a twelve month low of $23.89 and a twelve month high of $34.60. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.77 and a current ratio of 2.56. The stock has a market capitalization of $3.72 billion, a PE ratio of -23.33 and a beta of 0.52. The stock has a 50-day simple moving average of $26.42 and a 200 day simple moving average of $26.97.
Perrigo Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Friday, November 29th will be given a $0.276 dividend. The ex-dividend date of this dividend is Friday, November 29th. This represents a $1.10 annualized dividend and a yield of 4.04%. Perrigo’s dividend payout ratio is -94.02%.
Analysts Set New Price Targets
Several research firms have recently issued reports on PRGO. Jefferies Financial Group reiterated a “hold” rating and set a $30.00 price target (down previously from $50.00) on shares of Perrigo in a research note on Monday, September 23rd. StockNews.com raised Perrigo from a “hold” rating to a “buy” rating in a research report on Thursday, November 7th. Finally, Canaccord Genuity Group reissued a “buy” rating and issued a $42.00 price target on shares of Perrigo in a research report on Monday, September 30th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $37.00.
Check Out Our Latest Analysis on PRGO
Insider Transactions at Perrigo
In other news, Director Jeffrey B. Kindler sold 17,598 shares of the business’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $28.27, for a total transaction of $497,495.46. Following the sale, the director now directly owns 5,409 shares in the company, valued at approximately $152,912.43. The trade was a 76.49 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Katherine C. Doyle sold 8,954 shares of Perrigo stock in a transaction on Friday, September 13th. The stock was sold at an average price of $27.30, for a total transaction of $244,444.20. Following the sale, the director now owns 6,009 shares in the company, valued at $164,045.70. This represents a 59.84 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.70% of the company’s stock.
Perrigo Company Profile
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
See Also
- Five stocks we like better than Perrigo
- 3 Tickers Leading a Meme Stock Revival
- The Great CPU Race: AMD and Intel Battle for Dominance
- Using the MarketBeat Stock Split Calculator
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- Market Cap Calculator: How to Calculate Market Cap
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGO – Free Report).
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.